May 6, 2020
GRAIL in $390 Million series D financing round
Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a $390 million Series D financing round.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: GRAIL
September 28, 2019
GRAIL to Present New Data in Late-Breaking Oral Presentation at the European Society for Medical Oncology (ESMO) 2019 Congress
MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, Inc., a healthcare company focused on the early detection of cancer, today announced that new data…